Indian Journal of Pharmaceutical Sciences
Users online: 42
Scientific Publication of the Indian Pharmaceutical Association
Home Email this page Print this page Bookmark this page Decrease font size Default font size Increase font size
The Journal Search Current Issue Archives Instructions Online submission Login  


 
SHORT COMMUNICATION
Year : 2008  |  Volume : 70  |  Issue : 3  |  Page : 372-374
Simultaneous determination of valsartan and hydrochlorothiazide in tablets by RP-HPLC


Department of Pharmacy, School of Pharmacy, Shenyang Pharmaceutical University, 110016 Shenyang, China

Date of Submission13-Mar-2007
Date of Decision03-Dec-2007
Date of Acceptance14-Jun-2008

Correspondence Address:
F K Mo
Department of Pharmacy, School of Pharmacy, Shenyang Pharmaceutical University, 110016 Shenyang
China
Login to access the Email id


DOI: 10.4103/0250-474X.43006

PMID: 20046750

Get Permissions

   Abstract 

A simple, reproducible and efficient reverse phase high performance liquid chromatographic method was developed for simultaneous determination of valsartan and hydrochlorothiazide in tablets. A column having 200 4.6 mm i.d. in isocratic mode with mobile phase containing methanol:acetonitrile:water:isopropylalcohol (22:18:68:2; adjusted to pH 8.0 using triethylamine; v/v) was used. The flow rate was 1.0 ml/min and effluent was monitored at 270 nm. The retention time (min) and linearity range (g/ml) for valsartan and hydrochlorothiazide were (3.42, 8.43) and (5-150, 78-234), respectively. The developed method was found to be accurate, precise and selective for simultaneous determination of valsartan and hydrochlorothiazide in tablets.


Keywords: Valsartan, hydrochlorothiazide, RP-HPLC, simultaneous determination, tablets


How to cite this article:
Tian D F, Tian X L, Tian T, Wang Z Y, Mo F K. Simultaneous determination of valsartan and hydrochlorothiazide in tablets by RP-HPLC. Indian J Pharm Sci 2008;70:372-4

How to cite this URL:
Tian D F, Tian X L, Tian T, Wang Z Y, Mo F K. Simultaneous determination of valsartan and hydrochlorothiazide in tablets by RP-HPLC. Indian J Pharm Sci [serial online] 2008 [cited 2014 Jul 11];70:372-4. Available from: http://www.ijpsonline.com/text.asp?2008/70/3/372/43006


Valsartan, (S)-N-(1-Oxopentyl)-N-[[2'-(1H-tetrazol-5-yl) [1,1'-biphenyl]-4-yl]methyl]-L-valine, is an orally active specific angiotensin II receptor blocker effective in lowering blood pressure in hypertensive patients [1] . A number of high performance liquid chromatographic (HPLC) methods are available for separation and quantification of valsartan from pharmaceutical dosage forms [2] . Hydrochlorothiazide is a diuretic of the class of benzothiadiazines widely used in antihypertensive pharmaceutical formulations, alone or in combination with other drugs, which decreases active sodium reabsorption and reduces peripheral vascular resistance [3] . It is chemically 6-chloro-3,4-dihydro-2H-1, 2, 4-benzothiadiazine-7-sulfonamide-1,1-dioxide, and was successfully used as one content in association with other drugs [4],[5],[6],[7],[8],[9] in the treatment of hypertension. Simultaneous determination of both drugs is highly desirable as this would allow more efficient generation of clinical data and could be more cost-effective than separate assays. There are very few methods appearing in the literature for the simultaneous determination of valsartan and hydrochlorothiazide in tablets. Since these methods were based on HPLC and UV-derivative spectrophotometry [10],[11] , the procedure was inconvenient for determination and the run times were rather long. The aim of this study was to develop a simple, precise and accurate reverse-base high performance liquid chromatographic method to estimate valsartan and hydrochlorothiazide in tablets. This method was simple and rapid and provides accurate and precise results, as compared with other methods which have been reported. Criteria employed for assessing the suitability of said solvent system were cost-effectiveness in terms of time required for analysis, solvent noise and preparatory steps involved in the extraction of the drug from the formulation excipients for the estimation of drug contents. The retention times for valsartan and hydrochlorothiazide were 3.42 and 8.43 min, respectively. The typical chromatograms of the drugs are shown in [Figure 1]. The peak shapes of both drugs were symmetrical and asymmetry factor was less than 1.3.

Pharmaceutical grade valsartan and hydrochlorothiazide were supplied by National Institute for the Control of Pharmaceutical and Biological Products and were used without further purification. All chemicals and reagents were of HPLC grade and were purchased from Jiangsu Hanbon Sci. & Tech. Co. Ltd.

HPLC system consisted of a pump (model LC-10AT plus). Manual injector was used. Loop used was of 20-l capacity per injection. UV detector (model SPD-10AV plus) was used. Detection was carried out at 270 nm and the software used was Anstar Chromatographic Data System. Diamonsil (TM) C18 (200 4.6 mm, 5 m) column was used. Different mobile phases were tested in order to find the best conditions for composition of mobile phase was determined to be methanol- acetonitrile- water- isopropylalcohol (22:18:68:2; v/v), and adjusted pH value to 8 with triethylamine. Flow rate was set to 1.0 ml/min.

Standard stock solution containing 0.01 and 0.00157 mg/ml of valsartan and hydrochlorothiazide, respectively was prepared by dissolving 10 and 1.57 mg of both drugs in 1000 ml of mobile phase. For estimation of valsartan and hydrochlorothiazide in tablets, an accurately weighed quantity of tablet powder equivalent to 10 mg valsartan and 1.57 mg hydrochlorothiazide were transferred to a 1000 ml volumetric flask, diluted with mobile phase, sonicated for 10 min and further diluted to 1000 ml with mobile phase. The solution was sonicated before it was used to analysis.

The plot of peak area of standard solutions versus concentration was found to be linear in the range of 5-150 μg /ml and 78-234 μg /ml for valsartan and hydrochlorothiazide respectively and coefficient of correlation (r2 ) was 0.9997 and 0.9998, respectively.

Amounts of drug powder equivalent to 100% of label claim, respectively of valsartan and hydrochlorothiazide were accurately weighed and assayed. The system repeatability was determined by six repeated applications. Repeatability of sample application and measurement of peak area were expressed in terms of relative standard deviation. Method repeatability was obtained from relative standard deviation by repeating six times during the same day for intraday precision. Intermediate precision was also done.

The reversed-phase HPLC method was developed to provide a specific procedure suitable for the rapid quality control analysis of valsartan and hydrochlorothiazide as referee method for the developed derivative method. To evalutate HPLC method robustness, a few parameters were deliberately varied; the parameters included pH of buffer and differents percentages of methanol and acetonitrile in mobile phase. Specificity of the methods was determined by the complete separation of valsartan and hydrochlorothiazide with other oarameters like retention time, asymmetry and capacity factor. The condition of the method was exactly effective and efficient.

To study accuracy, reproducibility and precision of the proposed method, recovery experiments were carried out. The average percentage recovery of valsartan and hydrochlorothiazide was 99.2% and 98.8% respectively. The sample recovery in the formulation was in good agreement with what was claimed on the label. System suitability parameters are given in [Table 1]. Assay in the tablet dosage form was found to be 98.6% of valsartan and 97.8% of hydrochlorothiazide. The method was simple and the run time given was 15 min. The proposed method gives a good resolution between valsartan and hydrochlorothiazide within a short analysis time (<15 min) and can be conveniently adopted for routine quality control analysis.

To summarize, the method was evaluated in a mass of facets, such as best condition, linear relation including coefficient of correlation, robustness, accuracy, reproducibility and precision. All the parameters above showed that this method, which was fairly efficient and convenient, can be used to determine of Valsartan and Hydrochlorothiazide in tablets simultaneously.

 
   References Top

1.Markham A, Goa KL. Valsartan. A review of its pharmaco-logy and therapeutic use in essential hypertension. Drugs 1997;54:299-311.  Back to cited text no. 1    
2.Daneshtalab N, Lewanczuk RZ, Jamali F. High-performance liquid chromatographic analysis of angiotensin II receptor antagonist valsartan using a liquid extraction method. J Chromatogr B 2002;766:345-9.  Back to cited text no. 2    
3.Carlucci G, Palumbo G, Mazzeo P, Quaglia MG. Simultaneous determination of losartan and hydrochlorothiazide in tablets by high-performance liquid chromatography. J Pharm Biomed Anal 2000;23:185-9.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]
4.Schoenberger JA. Losartan with hydrochlorothiazide in the treatment of hypertension. J Hypertens 1995;13:S43-7.  Back to cited text no. 4    
5.Ramsay LE, Yeo WW. Double-blind comparison of losartan, lisinopril and hydrochlorothiazide in hypertensive patients with a previous angiotensin converting enzyme inhibitor-associated cough. J Hypertens 1995;13:(Suppl 1) S73-6.  Back to cited text no. 5    
6.McCrea JB, Lo MW, Tomasko L, Lin CC, Hsieh JY, Capra NL, et al . Absence of a pharmacokinetic interaction between losartan and hydrochlorothiazide. J Clin Pharmacol 1995;35:1200-6.  Back to cited text no. 6  [PUBMED]  [FULLTEXT]
7.Ruilope LM, Simpson RL, Toh J, Arcuri KE, Goldberg AI, Sweet CS. Controlled trial of losartan given concomitantly with different doses of hydrochlorothiazide in hypertensive patients. Blood Press 1996;5:32-40.  Back to cited text no. 7  [PUBMED]  
8.Conlin PR, Elkins M, Liss C, Vrecenak AJ, Barr E, Edelman JM. A study of losartan alone or with hydrochlorothiazide vs nifedipine GITS In eldely patients with diastolic hypertension. J Hum Hypertens 1998;12:693-700.  Back to cited text no. 8  [PUBMED]  
9.Del Castillo D, Campistol JM, Guirado L, Capdevilla L, Martinez JG, Pereira P, et al. Efficacy and safety of losartan in the treatment of hypertension in renal transplant patients. Kidney Int Suppl 1998;68:S135-9.  Back to cited text no. 9    
10.Hillaert S, Van den Bossche W. Simultaneous determination of hydrochlorothiazide and severl angiotensin-II-receptor antagonists by capillary electrophoresis. J Pharm Biomed Anal 2003;31:329-39.  Back to cited text no. 10  [PUBMED]  [FULLTEXT]
11.Satana E, Altinay S, Goger NG, Ozkan SA, Senturk Z. Simultaneous determination of valsartan and hydrochlorothiazide in tablets by first-derivative ultraviolet spectrophotometry and LC. J Pharm Biomed Anal 2001;25:1009-13.  Back to cited text no. 11    


    Figures

  [Figure 1]
 
 
    Tables

  [Table 1]

This article has been cited by
1 Total error-based validation including the experimental design-based robustness evaluation of a stability-indicating method for the simultaneous quantification of hydrochlorothiazide and valsartan in tablet formulations
M. Elkarbane,M. Amood Al-Kamarany,H. Bouchafra,M. Azougagh,Y. Cherrah,Ph. Hubert,Y. Vander Heyden,A. Bouklouze
Acta Chromatographica. 2014; 1(-1): 1
[Pubmed]
2 Simultaneous determination of aliskiren hemifumarate, amlodipine besylate, and hydrochlorothiazide in their triple mixture dosage form by capillary zone electrophoresis
Mohamed M. Salim,Walid M. Ebeid,Nahed El-Enany,Fathalla Belal,Mohamed Walash,Gabor Patonay
Journal of Separation Science. 2014; : n/a
[Pubmed]
3 Synchronized separation of seven medications representing most commonly prescribed antihypertensive classes by using reversed-phase liquid chromatography: Application for analysis in their combined formulations
Walid M. Ebeid,Ehab F. Elkady,Asmaa A. El-Zaher,Ramzia I. El-Bagary,Gabor Patonay
Journal of Separation Science. 2014; : n/a
[Pubmed]
4 Comparative study between derivative spectrophotometry and multivariate calibration as analytical tools applied for the simultaneous quantitation of Amlodipine, Valsartan and Hydrochlorothiazide
Hany W. Darwish,Said A. Hassan,Maissa Y. Salem,Badr A. El-Zeany
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2013; 113: 215
[Pubmed]
5 Chromatographic methods for the simultaneous determination of metoprolol tartrate and hydrochlorothiazide in the presence of hydrochlorothiazide degradation product
Nesrin K. Ramadan,Heba M. Mohamed,Azza A. Mostafa
JPC - Journal of Planar Chromatography - Modern TLC. 2013; 26(6): 510
[Pubmed]
6 Simultaneous determination of amlodipine, valsartan and hydrochlorothiazide by LCESI-MS/MS and its application to pharmacokinetics in rats
Shankar Ganesh Gadepalli,Pragney Deme,Madhusudana Kuncha,Ramakrishna Sistla
Journal of Pharmaceutical Analysis. 2013;
[Pubmed]
7 Sequential Spectrophotometric Method for the Simultaneous Determination of Amlodipine, Valsartan, and Hydrochlorothiazide in Coformulated Tablets
Hany W. Darwish,Said A. Hassan,Maissa Y. Salem,Badr A. El-Zeany
International Journal of Spectroscopy. 2013; 2013: 1
[Pubmed]
8 Ion-Pair LC Method for Simultaneous Determination of Aliskiren Hemifumarate, Amlodipine Besylate and Hydrochlorothiazide in Pharmaceuticals
Ramzia I. El-Bagary,Gabor Patonay,Asmaa A. Elzahr,Ehab F. Elkady,Walid A. Ebeid
Chromatographia. 2013;
[Pubmed]
9 Concurrent Estimation of Amlodipine Besylate, Hydrochlorothiazide and Valsartan by RP-HPLC, HPTLC and UV-Spectrophotometry
M. Sharma,C. Kothari,O. Sherikar,P. Mehta
Journal of Chromatographic Science. 2013;
[Pubmed]
10 Analysis of Sartans: A Review
Izabela Muszalska,Agnieszka Sobczak,Agnieszka Dolhan,Anna Jelinska
Journal of Pharmaceutical Sciences. 2013; : n/a
[Pubmed]
11 Simple and Sensitive Methods for the Determination of 2-(4'-Chloromethyl phenyl) Benzonitrile and 2-(4'-Bromomethyl phenyl) Benzonitrile Contents in Valsartan Drug Substance by Gas Chromatography
G. Amarnatha Reddy,K. Hussain Reddy,M. Narendra Kumar,Hemant kumar Sharma
ISRN Analytical Chemistry. 2013; 2013: 1
[Pubmed]
12 Validated RP-HPLC method for the simultaneous determination of amlodipine besylate, valsartan, and hydrochlorothiazide in bulk and in pharmaceutical formulation
K. Anandakumar, D. Jothieswari, R. Subathrai, D. V. Santhi, T. Vetrichelvan
Acta Chromatographica. 2012; 1(-1): 1
[VIEW]
13 Dual separation mode for simultaneous determination of antihypertensive drug combinations by high-performance liquid chromatography
Sameh Ahmed,Noha N. Atia,Niveen A. Mohamed
Talanta. 2011; 84(3): 666
[Pubmed]
14 Simultaneous determination of aliskiren and hydrochlorothiazide from their pharmaceutical preparations using a validated stability-indicating MEKC method
Maximiliano S. Sangoi, Micheli Wrasse-Sangoi, Paulo R. Oliveira, Clarice M. B. Rolim, Martin Steppe
Journal of Separation Science. 2011; 34(15): 1859
[VIEW]
15 RAPID SIMULTANEOUS DETERMINATION OF ALISKIREN AND HYDROCHLOROTHIAZIDE FROM THEIR PHARMACEUTICAL FORMULATIONS BY MONOLITHIC SILICA HPLC COLUMN EMPLOYING EXPERIMENTAL DESIGNS
Maximiliano da Silva Sangoi, Micheli Wrasse-Sangoi, Paulo Renato de Oliveira, Vtor Todeschini, Clarice Madalena Bueno Rolim
Journal of Liquid Chromatography & Related Technologies. 2011; 34(17): 1976
[VIEW]
16 Absorption correction method for estimation of amlodipine besylate, valsartan and hydrochlorothiazide in bulk and in combined tablet dosage form
Jothieswari, D., Anandakumar, K.
International Journal of Pharmacy and Pharmaceutical Sciences. 2011; 3(sup 3): 30-34
[Pubmed]
17 Dual separation mode for simultaneous determination of antihypertensive drug combinations by high-performance liquid chromatography
Ahmed, S., Atia, N.N., Mohamed, N.A.
Talanta. 2011; 84(3): 666-672
[Pubmed]
18 Formulation and bioequivalence of two valsartan tablets after a single oral administration
Zaid, A.N., Cortesi, R., Qaddomi, A., Khammash, S.
Scientia Pharmaceutica. 2011; 79(1): 123-135
[Pubmed]
19 QUANTITATIVE SIMULTANEOUS DETERMINATION OF AMLODIPINE, VALSARTAN, AND HYDROCHLOROTHIAZIDE IN EXFORGE HCT TABLETS USING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY AND HIGH-PERFORMANCE THIN-LAYER CHROMATOGRAPHY
Susheel John Varghese, Thengungal Kochupappy Ravi
Journal of Liquid Chromatography & Related Technologies. 2011; 34(12): 981
[VIEW]
20 Absorption correction method for the simultaneous estimation of amlodipine besylate, valsartan and hydrochlorothiazide in bulk and in combined tablet dosage form
Anandakumar, K., Jayamariappan, M.
International Journal of Pharmacy and Pharmaceutical Sciences. 2011; 3(1): 23-27
[Pubmed]
21 Combined effect of polarity and pH on the chromatographic behavior of some angiotensin II receptor antagonists and optimization of their determination in pharmaceutical dosage forms
Demiralay, E.C., Cubuk, B., Ozkan, S.A., Alsancak, G.
Journal of Pharmaceutical and Biomedical Analysis. 2010; 53(3): 475-482
[Pubmed]
22 Potentiometric determination of valsartan in a pharmaceutical preparation and its protonation constants
Aslan, N., Erden, P.E., Canel, E., Zeybek, B., Kili, E.
Asian Journal of Chemistry. 2010; 22(5): 4010-4016
[Pubmed]
23 Validated RP- HPLC method for the quantitative estimation of Valsartan in bulk and pharmaceutical dosage forms
Thanusha, G., Jose Gnana Babu, C., Channa Basavaraj, K.P., Reddy Panditi, V., Sharadha, C.
International Journal of ChemTech Research. 2010; 2(2)
[Pubmed]
24 Estimation of Valsartan and Nebivolol in pharmaceutical dosage forms by absorption ratio method
Chaudhary Ankit, B., Patel Rakesh, K., Chaudhary Sunita, A.
International Journal of Research in Pharmaceutical Sciences. 2010; 1(2): 108-112
[Pubmed]
25 Combined effect of polarity and pH on the chromatographic behavior of some angiotensin II receptor antagonists and optimization of their determination in pharmaceutical dosage forms
Ebru Cubuk Demiralay,Burcu Cubuk,Sibel A. Ozkan,Guleren Alsancak
Journal of Pharmaceutical and Biomedical Analysis. 2010; 53(3): 475
[Pubmed]
26
. ;
[Pubmed]



 

Top
Print this article  Email this article
 
  Search
   
   Next article
   Previous article 
   Table of Contents
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Article in PDF (258 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    Abstract
    References
    Article Figures
    Article Tables

 Article Access Statistics
    Viewed5078    
    Printed107    
    Emailed3    
    PDF Downloaded535    
    Comments [Add]    
    Cited by others 26    

Recommend this journal